Noubar Afeyan

Co-Founder at Moderna, Inc.

Noubar Afeyan

Noubar Afeyan

Co-Founder at Moderna, Inc.

Overview
Career Highlights

Flagship Ventures Management, Inc.
Fin.Co NV
Cellarity

RelSci Relationships

5302

Number of Boards

60

Birthday

07/1963

Age

57

Contact Data
Trying to get in touch with Noubar Afeyan? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Noubar Afeyan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

President at Epiva Biosciences, Inc.

Relationship likelihood: Strong

Director & Chief Executive Officer at Moderna, Inc.

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Executive Partner at Flagship Pioneering

Relationship likelihood: Strong

Special Partner at Flagship Pioneering

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

Founder at Fate Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Indigo Ag, Inc.

Relationship likelihood: Strong

Managing Partner at Flagship Pioneering

Relationship likelihood: Strong

Paths to Noubar Afeyan
Potential Connections via
Relationship Science
You
Noubar Afeyan
Co-Founder at Moderna, Inc.
Education
Ph.D. in Biochemical Engineering
Class of 1987

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

B.S. Chemical Engineering
Class of 1983

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Career History
Co-Founder
2019 - Current
Co-Founder
2009 - Current

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Co-Founder
2007 - Current

DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA.

Boards & Committees
Chairman
Prior - 2014

Essentient, Inc. develops transforming global nutrition. The company involves in research and development in biotechnology. The company was founded in 2008 and is headquartered in Cambridge, MA.

Chairman
2004 - 2010

Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA.

Director
2003 - 2008

Adaptive Therapeutics, Inc. develops pharmaceutical products. It develops drugs for applications in anti-bacterial, fungal, viral, and cancer therapeutics. The company was founded in 2002 and is headquartered in San Diego, CA

President, Board of Directors
Current
Member, International Advisory Board
Prior

The Moscow School of Management SKOLKOVO is the largest private business school in Russia established in 2006, when a number of Russian and international business leaders joined their effort to create a next generation business school. It was founded by 18 Russian and exterior companies and individuals, all of which are recognized industry leaders in their fields: oil and gas industry, metal industry, energy sector, investment, banking and insurance.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2018

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

$10K - $25K
2018

American Institute of Chemical Engineers is a private company headquartered in New York, NY, with subsidiaries in the United States. The firm operates as a professional organization for chemical engineers.The company says this about itself: AIChE is a professional society of more than 53,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nano technology, and chemical plant safety and security.

$50K +
2017

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Political Donations
$2,500
2012

Senator from Massachusetts

$2,300
2008

Former President of United States

$250
2008

President at Quincy Chamber of Commerce

Transactions
Details Hidden

LS Dissolution, Inc. raised money in a private placement transaction

Investments
Details Hidden

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.

Details Hidden

Kaleido Biosciences, Inc. engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. It offers microbiome metabolic therapies (MMT) which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.

Details Hidden

Indigo Agriculture, Inc. provides microbial solutions. The firm offers platform for microbiome product discovery and has generated a robust pipeline of candidates for seed, soil, and foliar applications in globally important crops, including corn, soy, wheat, cotton, and vegetables The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2014 and is headquartered in Boston, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
Davos, Switzerland
2012 World Economic Forum Annual Meeting

A record 2,600 business, government and civil society leaders – including nearly 40 heads of state or government – participated in the 42nd World Economic Forum Annual Meeting, which took place under the theme The Great Transformation: Shaping New Models. The record participation indicated the international community’s level of concern for the world today, as one crisis after another emerges. It also underscored the commitment of the Forum’s Members, Partners and communities to improving the state of the world.

Speaker
Los Angeles, CA, United States
2011 Milken Institute Global Conference

The 2011 Milken Institute Global Conference brings together some of the most extraordinary people in the world - from entrepreneurs and executives to philanthropists, scientists and Nobel laureates. Together they explore solutions to today's most pressing social, political and economic challenges.

Other Affiliations

Noubar Afeyan is affiliated with Cellarity, Moderna, Inc., DNIB Unwind, Inc., Flagship Ventures Management, Inc., Flagship Pioneering, Evelo Biosciences, Inc., Omega Therapeutics, Inc., Harvard University - Harvard Business School, Joule Unlimited Technologies, Inc., Sana Biotechnology, Inc., Kaleido Biosciences, Inc., Rubius Therapeutics, Inc., Seres Therapeutics, Inc., Axcella Health, Inc., National Competitiveness Foundation of Armenia, LS Dissolution, Inc., Codon Devices, Inc., Epitome Biosystems, Inc., Helicos BioSciences Corp., Selventa, Inc., Affinnova, Inc., BG Medicine, Inc., Color Kinetics, Inc., Celera Group, Applera Corporation, Life Technologies Corp., Celera Corp., Celera Genomics Group, EXACT Sciences Corp., Cephalon, Inc., PerSeptive Biosystems, Inc., Agenus Inc., Indigo Ag, Inc., Modernatx, Inc., Ensemble Therapeutics Corp., Permeon Biologics, Inc., Armenia 2020, Fin.Co NV, MIT Entrepreneurship Center, Massachusetts Institute of Technology - Sloan School of Management, The World Economic Forum, The World Economic Forum USA, Inc., Essentient, Inc., Codon Devices, Inc., Adaptive Therapeutics, Inc., Adnexus, Agenus Inc., ChemGenics Pharmaceuticals, Inc., EXACT Sciences Corp., PerSeptive Biosystems, Inc., T2 Biosystems, Inc., WikiCell Designs, Inc., Crystalplex Corp., AeroDesigns, Inc., Massachusetts Institute of Technology - Deshpande Center for Technological Innovation, Yale Climate & Energy Initiative, Armenia 2020, World Economic Forum Global Agenda Council on Emerging Technologies, Skolkovo Moscow School of Management, Skolkovo Institute of Science and Technology, Boston Symphony Orchestra, Inc., Whitehead Institute for Biomedical Research, Boston University - School of Medicine

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Noubar Afeyan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Noubar Afeyan's profile does not indicate a business or promotional relationship of any kind between RelSci and Noubar Afeyan.